Volume 27, Issue 124 (September & October 2019)                   J Adv Med Biomed Res 2019, 27(124): 1-7 | Back to browse issues page


XML Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Moghimi M, Mortazavi Y, Razavi-Dizaji S, Keyhanian S, Ghadimi Z, Baba Ali S, et al . Helicobacter pylori Eradication in Adult Patients with Acute Idiopathic Thrombocytopenic Purpura (ITP). J Adv Med Biomed Res 2019; 27 (124) :1-7
URL: http://journal.zums.ac.ir/article-1-5923-en.html
1- Dept. of Internal Medicine,Vali-e-Asr Hospital, Faculty of Medicine, Zanjan University of Medical Sciences, Zanjan, Iran
2- Zanjan Metabolic Diseases Research Center, Zanjan University of Medical Sciences, Zanjan, Iran , youmort@yahoo.com
3- Dept. of Internal Medicine, Faculty of Medicine, Azad University of Tonekabon, Tonekabon, Iran
4- Social Determinants of Health Research Center, Zanjan University of Medical Sciences, Zanjan, Iran
5- Dept. of Pharmacotherapy, Faculty of Pharmacy, Zanjan University of Medical Sciences, Zanjan, Iran
Abstract:   (146521 Views)

Background and Objective: Different studies have investigated the link between helicobacter pylori and extra digestive diseases such as idiopathic thrombocytopenic purpura. However, the relationship between ITP and H pylori is less clear. Most of the studies have focused on H pylori eradication in chronic ITP, so we focused on the effect of H pylori eradication on chronicity of ITP in adult patients with ITP.
Materials and Methods: Eighty five patients with acute ITP whose platelet count were less than 30x109/L were enrolled to the study. Urea breath test (UBT) was carried out for all the patients and based on its results; the patients were divided into 3 groups: Group I: H pylori positive patients who underwent standard triple therapy. Evaluation of H pylori eradication for this group was carried out one month and six months after the treatment. Group II: ITP patients negative for H pylori and Group III: ITP patients' positive for H pylori but without eradication therapy.
Results: 52(61.2%) patients were female and 33(38.8%) were male with mean age of 34.8±12.2 years. There was no significant difference between the mean age and gender in different groups. No significant difference was seen in mean platelet count at the baseline among the groups, but there was a significant statistical difference in mean platelet between the groups at the end of the first month. However, a significant difference was not seen in mean platelet count in months 2 to 6. Chronicity in group I was statistically less than the group III. Also, the chronicity rate in non-infected ITP patients was lower than the H pylori positive patients (P=0.03). Likewise, the chronicity rate was lower in the intervention group than in the control group (P=0.035).
Conclusion: Our results show that eradication of H pylori can reduce the chronicity rate in adult patients with ITP. Further studies on larger number of patients with longer follow-up are recommended.

Full-Text [PDF 267 kb]   (156308 Downloads) |   |   Full-Text (HTML)  (3093 Views)  

Our results show that eradication of H pylori can reduce the chronicity rate in adult patients with ITP. Further studies on larger number of patients with longer follow-up are recommended.


Type of Study: Original Research Article | Subject: Clinical Medicine
Received: 2020/02/8 | Accepted: 2020/02/8 | Published: 2020/02/8

References
1. Neunert CE. Current management of immune thrombocytopenia. Hematology Am Soc Hematol Educ Program. 2013; 2013: 276-82. [DOI:10.1182/asheducation-2013.1.276]
2. Provan D, Stasi R, Newland AC, et al. International consensus report on the investigation and management of primary immune thrombocytopenia. Blood. 2010; 115(2):168-86. [DOI:10.1182/blood-2009-06-225565]
3. Longo D , Fauci A, Kasper D , et al . Harrison's Principle of Internal Medicine. 18thed. Vol 1&2 , McGraw-Hill, NewYork, 2012. 965-69.
4. Hee Sang Tag, Ho Sup Lee, Su-Hyeon Jung, et al. Effects of Helicobacter pylori eradication in patients with immune thrombocytopenic purpura. Korean J Hematol .2010;45(2): 127-32. [DOI:10.5045/kjh.2010.45.2.127]
5. Suerbaum S , Michetti P. Helicobacter pylori infection. New Eng J Med. 2002, 347(15): 1175-86. [DOI:10.1056/NEJMra020542]
6. Kim YI, Cho SJ, Lee JY, et al. Effect of Helicobacterpylori eradication on long-term survival after distal gastrectomy for gastric cancer. Cancer Res Treat.2016; 48 (3); 1020-29. [DOI:10.4143/crt.2015.264]
7. Vanegas YAM, Vishnu P. Management of Helicobacter pylori in patients with immune thrombocytopenia. Hamostaseologie. 2019; 39(3):279-83 19. doi: 10.1055/s-0039-1683974. [Epub ahead of print]. [DOI:10.1055/s-0039-1683974]
8. Emilia G, Longo G, Luppi M, et al. Helicobacter pylori eradication can induce platelet recovery in idiopathic thrombocytopenic purpura. Blood . 2001;97:812-814. [DOI:10.1182/blood.V97.3.812]
9. Sato R, Murakami K, Watanabe K, et al. Effect of Helicobacter pylori eradication on platelet recovery in patients with chronic idiopathic thrombocytopenic purpura. Arch Intern Med. 2004;164:1904-7. [DOI:10.1001/archinte.164.17.1904]
10. Stasi R, Rossi Z, Stipa E, Amadori S, Newland A, Provan D. Helicobacter pylori eradication in the management of patients with idiopathic thrombocytopenic purpura. Am J Med. 2005;118 (4): 414-19. [DOI:10.1016/j.amjmed.2004.09.014]
11. InabaT, Mizuno M, Take S, et al. Eradication of Helicobacter pylori increases platelet count in patients with idiopathic thrombocytopenic purpura in Japan. Eur J Clin Invest. 2005; 35(3): 214-19. [DOI:10.1111/j.1365-2362.2005.01471.x]
12. Treepongkaruna S, Sirachainan N, Kanjanapongkul S, et al. Absence of platelet recovery following Helicobacter pylori eradication in childhood chronic idiopathic thrombocytopenic purpura: a multi-center randomized controlled trial. Pediatric Blood & Cancer. 2009; 53(1): 72-77. [DOI:10.1002/pbc.21991]
13. Tang Y, Wang SC, Wang LJ et al. Clinical significance of Helicobacter pylori in children with idiopathic thrombocytopenic purpura. Zhongguo Shi Yan Xue Ye XueZaZhi. 2013; 21(2): 419-21.
14. Arnold DM , Bernotas A, Nazi I, et al. Platelet count r esponse To H. Pylori treatment in patients with immune thrombocytopenic purpura with and without H. Pylori infection: A systematic review. Haematologica. 2009; 94: 850-56. [DOI:10.3324/haematol.2008.005348]
15. Arnold DM,Stasi R. Does Helicobacter pylori eradication therapy result in a platelet count improvement in adults with immune thrombocytopenic purpura regardless of H.pylori infection? Hematology Am Soc Hematol Educ Program.2008;2008: 31-2. [DOI:10.1182/asheducation-2008.1.31]
16. ShaikhK H, Ahmed S, Ayyub M, Anwar J. Association of Helicobacter Pylori infection with Idiopathic Thrombocytopenic Purpura. J Pak Med Assoc .2009; 59(10):660-3.
17. Stasi R, Sarpatwari A, Segal JB, et al. Effects of eradication of Helicobacter pylori infection in patients with immune thrombocytopenic purpura: a systematic review. Blood. 2009; 113: 1231-40. [DOI:10.1182/blood-2008-07-167155]
18. Semple JW, Aslam R, Kim M, Speck ER, Freedman J. Platelet-bound lipopolysaccharide enhances Fc receptor-mediated phagocytosis of IgG-opsonized platelets. Blood. 2007 ;109(11):4803-5. [DOI:10.1182/blood-2006-12-062695]
19. Gasbarrini A, Franceschi F, Tartaglione R, Landolfi R, PolaP,Gasbarrini G. Regression of autoimmune thrombocytopenia after eradication of Helicobacter pylori. Lancet, 1998, 352(9131): 878. [DOI:10.1016/S0140-6736(05)60004-9]
20. Inaba T, Mizuno M, Take S, et al. Eradication of Helicobacter pyloriincreases platelet count in patients with idiopathic thrombocytopenic purpura in Japan. Eur J Clin Invest, 2005; 35(3):214-9. [DOI:10.1111/j.1365-2362.2005.01471.x]
21. Kohda K, Kuga T, Kogawa K, et al. Effect of Helicobacter pylori eradication on platelet recovery in Japanese patients with chronic idiopathic thrombocytopenic purpura and secondary autoimmune thrombocytopenic purpura. Br J Haematol. 2002; 118:(2):584-8. [DOI:10.1046/j.1365-2141.2002.03612.x]
22. Suzuki T, Matsushima M, Masui A, et al. Effect of Helicobacter pylori eradication in patients with chronic idiopathic thrombocytopenic purpura. A randomized controlled trial. Am J Gastroenterol. 2005; 100 (6):1265-70. [DOI:10.1111/j.1572-0241.2005.41641.x]
23. Song MK, Chung JS, Shin HJ, Choi YJ, Cho GJ. Outcome of immunosuppressive therapy with Helicobacter pylori eradication therapy in patients with chronic idiopathic thrombocytopenic purpura. J Korean Med Sci. 2008; 23(3): 445-51. [DOI:10.3346/jkms.2008.23.3.445]
24. Gan GG, Norfaizal AL, Bee PC, Chin EF, Habibah AH, Goh KL. Helicobacter pylori infection in chronic immune thrombocytopenic purpura patients in Malaysia. Med J Malaysia. 2013; 68 (3): 231-3.
25. Veneri D, Bonani A, Franchini M, Fedrizzi A, Pizzolo G. Idiopathic thrombocytopenic and Helicobacter pylori infection: platelet count increase and early eradication therapy. Blood Transfus. 2011; 9(3): 340-2.

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2025 CC BY-NC 4.0 | Journal of Advances in Medical and Biomedical Research

Designed & Developed by : Yektaweb